Genmab A/S
GNMSF
$249.00
-$0.45-0.18%
OTC PK
| 03/31/2026 | 06/30/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 70.97% | 72.31% | 72.31% | -66.25% | -64.51% |
| Total Depreciation and Amortization | 26.67% | -25.00% | 0.00% | 50.50% | -2.65% |
| Total Amortization of Deferred Charges | 383.33% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 475.00% | -18,600.00% | -18,600.00% | 100.57% | 100.54% |
| Change in Net Operating Assets | -144.66% | -240.00% | -240.00% | 6,023.95% | 837.13% |
| Cash from Operations | -99.00% | -78.40% | -78.40% | -32.26% | -25.95% |
| Capital Expenditure | 61.54% | 16.67% | 16.67% | 14.83% | 10.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.24% | 216.13% | 216.13% | -184.31% | -223.25% |
| Cash from Investing | 99.84% | 160.47% | 160.47% | 28.70% | -466.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,350.00% | -100.00% | -100.00% | -198.20% | -- |
| Issuance of Common Stock | -71.43% | 500.00% | 500.00% | -61.82% | -90.91% |
| Repurchase of Common Stock | -3,566.67% | -3,300.00% | -3,300.00% | 48.91% | -50.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.38% | -3,023.08% | -3,023.08% | 39.65% | -3,132.42% |
| Foreign Exchange rate Adjustments | -175.00% | -162.50% | -162.50% | -54.56% | -92.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -321.74% | -235.15% | -235.15% | -33.51% | -52.44% |